Global Female Contraceptive Market 2018-2022

女性用避妊の世界市場2018-2022:避妊具、避妊薬

◆タイトル:Global Female Contraceptive Market 2018-2022
◆商品コード:IRTNTR20529
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018年2月20日
◆ページ数:136
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、女性用避妊の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、女性用避妊の世界市場規模及び予測、製品別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。

About Female ContraceptiveFemale contraceptives are used by women for family planning and to avoid unintended pregnancies.
Technavio’s analysts forecast the global female contraceptive market to grow at a CAGR of 3.44 % during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global female contraceptive market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of female contraceptive.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Female Contraceptive Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Allergan
• Bayer
• Lupin Pharmaceuticals
• Merck
• Pfizer
• Foundation Consumer Healthcare

[Market driver]
• Evolving consumer perspective
• For a full, detailed list, view our report

[Market challenge]
• Irregularities in sex education in developed countries
• For a full, detailed list, view our report

[Market trend]
• Increase in use of female condoms
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT
• Overview
• Comparison by product
• Female contraceptive devices
• Female contraceptive drugs
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Female contraceptive market in Americas
• Female contraceptive market in EMEA
• Female contraceptive market in APAC
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Increase in use of female condoms
• High disposable income in US
• Advent of smart condoms

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Allergan
• Bayer1
• Lupin Pharmaceuticals
• Merck
• Pfizer
• Foundation Consumer Healthcare
• Other prominent vendors

PART 15: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Parent market
Exhibit 02: Global contraceptive market: Segments
Exhibit 03: Market characteristics
Exhibit 04: Global female contraceptive market: Segments
Exhibit 05: Advantages and disadvantages of different types of contraceptives
Exhibit 06: Market definition: Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global female contraceptive market 2017-2022 ($ millions)
Exhibit 10: Global female contraceptive market: Year-over-year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition: Five forces 2017
Exhibit 19: Global female contraceptive market: Segmentation by product 2017-2022 (% share)
Exhibit 20: Types of female contraceptive devices and drugs
Exhibit 21: Comparison by product
Exhibit 22: Global female contraceptive devices market 2017-2022 ($ millions)
Exhibit 23: Global female contraceptive devices market: Year-over-year growth 2018-2022 (%)
Exhibit 24: Global IUDs market 2017-2022 ($ millions)
Exhibit 25: Global female sterilization market 2017-2022 ($ millions)
Exhibit 26: Global subdermal contraceptive implants market 2017-2022 ($ millions)
Exhibit 27: Global vaginal rings market 2017-2022 ($ millions)
Exhibit 28: Global female condoms market 2017-2022 ($ millions)
Exhibit 29: Global nonsurgical permanent contraception market 2017-2022 ($ millions)
Exhibit 30: Global contraceptive diaphragms market 2017-2022 ($ millions)
Exhibit 31: Global contraceptive sponges market 2017-2022 ($ millions)
Exhibit 32: Global female contraceptive drugs market 2017-2022 ($ millions)
Exhibit 33: Global female contraceptive drugs market: Year-over-year growth 2018-2022 (%)
Exhibit 34: Global birth control pills market 2017-2022 ($ millions)
Exhibit 35: Global emergency contraceptive pills market 2017-2022 ($ millions)
Exhibit 36: Market opportunity by product
Exhibit 37: Customer landscape
Exhibit 38: Global female contraceptive market: Segmentation by geography 2017-2022 (% share)
Exhibit 39: Regional comparison
Exhibit 40: Female contraceptive market in Americas 2017-2022 ($ millions)
Exhibit 41: Female contraceptive market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 42: Top-three countries in Americas
Exhibit 43: Female contraceptive market in EMEA 2017-2022 ($ millions)
Exhibit 44: Female contraceptive market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 45: Top-three countries in EMEA
Exhibit 46: Female contraceptive market in APAC 2017-2022 ($ millions)
Exhibit 47: Female contraceptive market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 48: Top-three countries in APAC
Exhibit 49: Market opportunity
Exhibit 50: State-wise disposable income in US 2015
Exhibit 51: Vendor landscape
Exhibit 52: Landscape disruption
Exhibit 53: Vendors covered
Exhibit 54: Vendors covered
Exhibit 55: Vendor classification
Exhibit 56: Market positioning of vendors
Exhibit 57: Allergan: Overview
Exhibit 58: Allergan: Business segments
Exhibit 59: Allergan: Organizational developments
Exhibit 60: Allergan: Geographic focus
Exhibit 61: Allergan: Segment focus
Exhibit 62: Allergan: Key offerings
Exhibit 63: Bayer: Overview
Exhibit 64: Bayer: Business segments
Exhibit 65: Bayer: Organizational developments
Exhibit 66: Bayer AG: Geographic focus
Exhibit 67: Bayer: Segment focus
Exhibit 68: Bayer: Key offerings
Exhibit 69: Lupin Pharmaceuticals: Overview
Exhibit 70: Lupin Pharmaceuticals: Business segments
Exhibit 71: Lupin Pharmaceuticals: Organizational developments
Exhibit 72: Lupin Pharmaceuticals: Geographic focus
Exhibit 73: Lupin Pharmaceuticals: Segment focus
Exhibit 74: Lupin Pharmaceuticals: Key offerings
Exhibit 75: Merck: Overview
Exhibit 76: Merck: Business segments
Exhibit 77: Merck: Organizational developments
Exhibit 78: Merck: Geographic focus
Exhibit 79: Merck: Segment focus
Exhibit 80: Merck: Key offerings
Exhibit 81: Pfizer: Overview
Exhibit 82: Pfizer: Business segments
Exhibit 83: Pfizer: Organizational development
Exhibit 84: Pfizer: Geographic focus
Exhibit 85: Pfizer: Segment focus
Exhibit 86: Pfizer: Key offerings
Exhibit 87: Foundation Consumer Healthcare: Overview
Exhibit 88: Foundation Consumer Healthcare: Business segments
Exhibit 89: Foundation Consumer Healthcare: Organizational developments
Exhibit 90: Foundation Consumer Healthcare: Geographic focus
Exhibit 91: Foundation Consumer Healthcare: Segment focus
Exhibit 92: Foundation Consumer Healthcare: Key offerings



【掲載企業】

Allergan, Bayer, Lupin Pharmaceuticals, Merck, Pfizer, and Foundation Consumer Healthcare

★調査レポート[女性用避妊の世界市場2018-2022:避妊具、避妊薬] (Global Female Contraceptive Market 2018-2022 / IRTNTR20529)販売に関する免責事項
[女性用避妊の世界市場2018-2022:避妊具、避妊薬] (Global Female Contraceptive Market 2018-2022 / IRTNTR20529)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆